Immune dysregulation in MDS includes abnormal levels and activity of tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β) [35], interferon- (IFN-) γ, and interleukin- (IL-) 6 [14]. Here, TGFB1 is linked to myelodysplastic syndrome.